Skip to main content
. 2021 Jun 30;10(13):e020917. doi: 10.1161/JAHA.121.020917

Figure 1. Receiver operating characteristic curves showing the levels of MRproANP and sST2 measured before the procedure in peripheral venous blood that best predict the recurrence of atrial fibrillation up to 1 year after catheter ablation.

Figure 1

AUC indicates area under the curve; MRproANP, midregional N‐terminal pro–atrial natriuretic peptide; and sST2, soluble suppression of tumorigenicity 2.